authors
- Lynch, John R
- Wang, Haichen
- Mace, Brian
- Leinenweber, Stephen
- Warner, David S
- Bennett, Ellen R
- Vitek, Michael P
- McKenna, Suzanne
- Daniel Laskowitz, MD, MHS
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2005
published in
- Experimental neurology Journal
has subject area
- Animals
- Anti-Inflammatory Agents
- Apolipoprotein E4
- Apolipoproteins E
- Binding Sites
- Blood-Brain Barrier
- Brain Edema
- Brain Injuries
- Cytokines
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Encephalitis
- Head Injuries, Closed
- Injections, Intravenous
- Low Density Lipoprotein Receptor-Related Protein-1
- Male
- Mice
- Mice, Inbred C57BL
- Movement Disorders
- Neuroprotective Agents
- Peptide Fragments
- Recovery of Function
- Time Factors